Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pravadoline: profile in isolated tissue preparations.

S J Ward1, D Mastriani, F Casiano

  • 1Department of Neurosciences, Sterling Research Group, Rensselaer, New York.

The Journal of Pharmacology and Experimental Therapeutics
|December 1, 1990
PubMed
Summary

Pravadoline, a cyclooxygenase-inhibiting analgesic, exhibits distinct pharmacological actions beyond COX inhibition. Its effects on smooth muscle contractions suggest novel therapeutic mechanisms for pain management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Balloon expandable stents for systemic venous pathway stenosis late after Mustard's operation.

Heart (British Cardiac Society)·1998
Same author

Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.

Cancer research·1998
Same author

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

The Journal of clinical investigation·1998
Same author

Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia.

European journal of clinical investigation·1998
Same author

Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.

The Journal of endocrinology·1998
Same author

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Bone marrow transplantation·1998

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Discovery

Background:

  • Pravadoline is a novel cyclooxygenase (COX)-inhibiting analgesic.
  • Its preclinical activity profile differs from other COX inhibitors.
  • The study investigates potential additional pharmacologic actions of pravadoline.

Purpose of the Study:

  • To determine if pravadoline has pharmacologic actions beyond cyclooxygenase inhibition.
  • To characterize the mechanism of action for pravadoline's effects on isolated tissues.

Main Methods:

  • Assessed pravadoline's effect on neuronally stimulated contractions in guinea pig ileum and mouse vas deferens.
  • Compared pravadoline's effects with structural analogs lacking COX inhibitory activity.
  • Investigated receptor interactions including muscarinic cholinergic, adrenergic, serotonergic, opioid, purinergic, neurokinin-1, bradykinin, and prostaglandin receptors.

Related Experiment Videos

Main Results:

  • Pravadoline inhibited contractions in guinea pig ileum and mouse vas deferens preparations.
  • These inhibitory effects were mimicked by structural analogs lacking COX inhibition.
  • The mechanism did not involve known receptor interactions, suggesting a novel presynaptic pathway.

Conclusions:

  • Pravadoline exhibits inhibitory effects in isolated tissues via a mechanism independent of cyclooxygenase inhibition.
  • This presynaptic mechanism does not involve known receptor targets.
  • Further research is needed to understand the in vivo relevance of this novel mechanism for aminoalkyindole analogs.